Appili Therapeutics Inc.
APLI.TOTSXHealthcare● Active
$0.02
+$0.00(+0.00%)
Market Cap$1925490
P/E Ratio—
52W High$0.04
52W Low$0.01
Appili Therapeutics Inc. (APLI.TO) · Cash Flow
Annual, quarterly, or TTM views · SEC 10-K & 10-Q via FMP · adjust period and M/B/T below.
FMP · APLI.TO · as of 2026-06-10
Financial statements
Operating CF · CapEx · Free Cash Flow
| Breakdown | 2025-03 | 2024-03 | 2023-03 | 2022-03 | 2021-03 |
|---|---|---|---|---|---|
| Operating Activities | |||||
| Net Income | ($2.62M) | ($3.78M) | ($9.24M) | ($25.12M) | ($14.33M) |
| Depreciation & Amort. | $0.01M | $0.01M | $0.01M | $0.01M | $0.01M |
| Stock-Based Comp. | $0.12M | $0.19M | $0.88M | $2.04M | $1.17M |
| Change in Working Capital | ($0.23M) | $0.66M | ($3.24M) | $2.49M | $1.64M |
| Net Cash from Operations | $0.87M | ($2.46M) | ($10.10M) | ($19.08M) | ($11.45M) |
| Investing Activities | |||||
| Capital Expenditure | ($0.00M) | ($0.03M) | ($0.00M) | $0.00M | ($0.01M) |
| Purchases of Investments | $0.00M | $0.00M | $0.00M | $0.00M | ($20.01M) |
| Sales of Investments | $0.00M | $0.00M | $0.00M | $5.06M | $15.03M |
| Net Cash from Investing | ($0.00M) | ($0.03M) | ($0.00M) | $5.06M | ($4.99M) |
| Financing Activities | |||||
| Common Stock Repurchased | $0.00M | $0.00M | $0.00M | $0.00M | $0.00M |
| Dividends Paid | $0.00M | $0.00M | $0.00M | $0.00M | $0.00M |
| Debt Issued / Repaid | $0.26M | $0.20M | $2.41M | $3.83M | ($0.02M) |
| Net Cash from Financing | $0.19M | $0.12M | $5.91M | $9.56M | $17.02M |
| Free Cash Flow | |||||
| Free Cash Flow | $0.87M | ($2.49M) | ($10.10M) | ($19.08M) | ($11.46M) |
| FCF Margin %(computed) | 862.63% | -301.44% | — | — | — |
Data source: Financial Modeling Prep · Last updated: 2026-06-10 · CAD · M
Explore more Appili Therapeutics Inc. data
About Appili Therapeutics Inc. (APLI.TO) Cash Flow Statement
Appili Therapeutics Inc. generated operating cash flow of $0.00B and free cash flow of $0.00B for 2025 — a FCF margin of 862.63%. Capital expenditure was ($0.00B).
Frequently asked questions
APLI.TO · 4 questionsAppili Therapeutics Inc. generated free cash flow of $0.00B for 2025, up 134.7% year-over-year.
APLI.TO free cash flowFCF margincash flow yield
· Source: FMP /stable/cash-flow-statement · SEC EDGAR Form 10-K & 10-Q · As of 2026-06-10